Shailesh Maingi is the Managing Partner of Kineticos Life Sciences which he founded in 2007. Shailesh serves on the Investment Committees of all funds and leads the strategic direction of funds and the Management Company. Shailesh is active in sourcing new investment opportunities and overseeing active portfolio companies for the Fund. Shailesh is Adjunct Faculty at the University of North Carolina. Shailesh is Founder and Chair of Inceptor Bio, LLC, a cell therapy biotechnology company focused on CAR-T. He is also Board Director at Kincell Bio, a cell therapy CDMO. Previously, Shailesh served as a Board Director at Arranta Bio and Gallus Biopharmaceuticals and a number of biotechnology companies including Locus Biosciences. In 2018, Shailesh co-founded the InVincible Cancer Research Fund, a non-profit funding breakthrough science. Prior to founding Kineticos, Shailesh was a senior executive at Cardinal Health and Sigma-Aldrich. He started his career as a research and development scientist with Roche Diagnostics. Shailesh earned a Bachelor of Science in Chemistry from the University of North Carolina at Chapel Hill and a Master in Business Administration from Golden Gate University.
Panel of investors in AMR will discuss deal dynamics and areas of particular interest.